Yi Xiang
10 Papers
Yi Xiang is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 4, co-authored 8 publications.
Chat about Author
Papers
High cell density and high-resolution 3D bioprinting for fabricating vascularized tissues
Shangting You,Yi Xiang,Henry H. Hwang,David B. Berry,Wisarut Kiratitanaporn,Jiaao Guan,Emmie Yao,Min Tang,Sheng Zhong,Xinyue Ma,Daniel Wangpraseurt,Yazhi Sun,Ting-Yu Lu,Shaochen Chen +13 more
TL;DR: In this paper , the authors developed a novel approach to mitigate this scattering-induced deterioration of bioprinting resolution by adding iodixanol to the bioink, which enables a 10-fold reduction in light scattering and a substantial improvement in fabrication resolution.
97
3D bioprinting of complex tissues in vitro: state-of-the-art and future perspectives
TL;DR: A review of 3D printed tissue models can be found in this paper , where the authors discuss the recent advancement of printing techniques and bio-ink sources, which have been spurred on by the increasing demand for modeling tactics and have facilitated the development of the refined tissue models as well as the modeling strategies.
Bioprinted Living Coral Microenvironments Mimicking Coral‐Algal Symbiosis
Daniel Wangpraseurt,Yazhi Sun,Shangting You,Sing Teng Chua,Samantha K. Noel,H. F. Willard,David B. Berry,Alexander M. Clifford,Sydney Plummer,Yi Xiang,Henry H. Hwang,Jaap A. Kaandorp,Julia M. Diaz,Todd C. La Jeunesse,Mathieu Pernice,Silvia Vignolini,Martin Tresguerres,Shaochen Chen +17 more
TL;DR: The bioprinted living coral microhabitats replicate the diffusion‐related phenomena that underlie the functioning and breakdown of the coral‐algal symbiosis and can be exploited for the additive manufacturing of synthetic designer corals.
23
3D Printing Approaches to Engineer Cardiac Tissue
TL;DR: A detailed review of the 3D printing technologies and bioink materials used in the creation of a heart tissue can be found in this paper , where the authors discuss the potential of engineered heart tissues in biomedical applications.
COVID-19 vaccines based on viral nanoparticles displaying a conserved B-cell epitope show potent immunogenicity and a long-lasting antibody response
Jessica Fernanda Affonso de Oliveira,Zhongchao Zhao,Yi Xiang,Matthew D Shin,Xinyi Deng,Sourabh Shukla,Shaochen Chen,Nicole F. Steinmetz +7 more
TL;DR: This article developed COVID-19 vaccine candidates based on the highly conserved SARS CoV-2, 809-826 B-cell peptide epitope (denoted 826) conjugated to cowpea mosaic virus (CPMV) nanoparticles and bacteriophage Qβ virus-like particles, both platforms have exceptional thermal stability and facilitate epitope delivery with inbuilt adjuvant activity.
4